Cardiac rehabilitation devices are used by patients suffering from heart diseases. Various types of cardiac rehabilitation devices available in the market include heart rate monitors,...
Electronic Health Record (EHR) Industry Worth US$ 20,318.02 million by 2028
EHR is a digital version of patient’s medical records. EHRs are patient-centered and real-time records that make patient data available instantly and securely to authorized healthcare professionals. It contains patient's medical history, medications, allergies, treatment plans, diagnoses, immunization dates, radiology images, and laboratory test results. Increasing adoption of electronic health records (EHRs), growing i... moreElectronic Health Record (EHR) Industry Worth US$ 20,318.02 million by 2028
EHR is a digital version of patient’s medical records. EHRs are patient-centered and real-time records that make patient data available instantly and securely to authorized healthcare professionals. It contains patient's medical history, medications, allergies, treatment plans, diagnoses, immunization dates, radiology images, and laboratory test results. Increasing adoption of electronic health records (EHRs), growing incidences of medication errors and rising incentives by federal government is driving the growth of the market.
Electronic Health Record (EHR) Market was valued at US$ 14,054.05 million in 2020 and it is projected to reach US$ 20,318.02 million by 2028; it is expected to grow at a CAGR of 4.9% during 2021–2028.
Market leaders operating in the market have undertaken various organic growth strategies in the Electronic Health Record (EHR) Market. The Electronic Health Record (EHR) market majorly consists of the players including. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
The growth of the electronic health record (EHR) market can be attributed to the factors such as the increasing adoption of Electronic Health Records (EHRs), rising incentives by federal government, and growing incidences of medication errors. However, concerns regarding data privacy and physician burnout hinder the market growth. Cerner Corporation, Computer Programs and Systems, Inc., Allscripts Healthcare Solutions, Inc., McKesson Corporation, Epic Systems Corporation, NextGen Healthcare, eClinicalWorks, Greenway Health, AdvancedMD, Inc., and CureMD Healthcare are among the major companies operating in the market.
In Apr-2021- NextGen Healthcare, Inc., announced the availability of its expanded platform for ambulatory providers, the spring ‘21 release of NextGen Enterprise. The platform also gives patients easier access to their medical records and to their care team, which strengthens the patient’s loyalty to the practice.
In Feb-2021- Pexip, a leading provider of enterprise video conferencing and collaboration solutions, announced a native integration with the electronic health record system, Epic. With a focus on providing an easy to use, secure system for patients and healthcare providers, the integration makes it simple to start a scheduled video meeting.
In Oct-2020- Epic to use InterSystems as data foundation for latest EHR release. Using the IRIS platform will allow Epic customers access to larger datasets and provide enhancements in asynchronous mirroring.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Procedure Trays Industry Worth US$ 8,768.9 million by 2027
In recent years, there had been considerable development in the field of procedure trays. The growing surgical procedures have increased the demand for surgical instruments. Procedure trays offer benefits such as performing surgical procedures like hip, hand, and pacemaker surgeries with ease and accuracy. An enormous amount of time can be saved, during the surgical procedure and in the preparations for an operation. Gaining time means ... moreProcedure Trays Industry Worth US$ 8,768.9 million by 2027
In recent years, there had been considerable development in the field of procedure trays. The growing surgical procedures have increased the demand for surgical instruments. Procedure trays offer benefits such as performing surgical procedures like hip, hand, and pacemaker surgeries with ease and accuracy. An enormous amount of time can be saved, during the surgical procedure and in the preparations for an operation. Gaining time means that it is possible to work more efficiently and thus to optimize the planning of operations. Operation theatre logistics are simplified. There is a reduction in the number of activities required to get the right products to the right place on time. The fact that custom procedure trays are supplied just in time means that the hospital can simplify its logistics and control its costs. The benefits offered by custom procedure trays is anticipated to increase the demand for procedure trays in the forecast period.
The Procedure Trays Market is expected to reach US$ 21,725.7 Mn in 2027 from US$ 8,768.9 Mn in 2018. The market is estimated to grow with a CAGR of 10.8% from 2019-2027.
The report highlights the trends prevalent in the global procedure trays market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to benefits offered by customize procedure trays, increase in the number of surgical procedures, and introduction of rules and regulations to implement better healthcare facilities.
Some of the prominent players operating in procedure trays market are, Biometrix, Medica Europe BV, 3M, BD, Owens & Minor, Inc., Medline Industries, Inc., Mölnlycke Health Care AB, Nelipak Corporation, Teleflex Incorporated, Cardinal Health, Inc. among the others. The market players are focused on bringing mergers and acquisitions to sustain their position in the market. For instance, in January 2019 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the acquisition of C. R. Bard, Inc. (NYSE: BCR). C. R. Bard, Inc. provides urology trays, Suprapubic Trays, dressing trays, and others. This helped BD to enhance its existing product offerings. The developments performed by the companies are helping the market to grow in the coming years.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Genome Editing Industry Worth US$ 16.98 billion by 2028
Genome editing technologies enable scientists to change DNA, leading to changes in physical traits, like eye color and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. CRISPR is simpler, faster, cheaper, and more accurate than older genome editing methods. Many scientists who perform... moreGenome Editing Industry Worth US$ 16.98 billion by 2028
Genome editing technologies enable scientists to change DNA, leading to changes in physical traits, like eye color and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. CRISPR is simpler, faster, cheaper, and more accurate than older genome editing methods. Many scientists who perform genome editing now use CRISPR.
According to the World Health Organization (WHO), cancer is the biggest cause of death worldwide, with approx. 10 million deaths in 2020. Overall, the global burden of cancer incidence and death is rapidly increasing, reflecting both population aging and growth, as well as changes in the prevalence and distribution of the key risk factors, many of which are related to socio-economic development. As per the recent estimates from CANCER TODAY, the incidence of cancer has been increasing at an alarming rate, making hepatocellular carcinoma (HCC) the fifth most common cancer in men and the seventh most common cancer in women. HCC is likely to contribute to ~5.6% of all human cancers, thereby increasing the burden in 2020. The HCC is known to be the second leading cause of cancer-related deaths worldwide. Almost 85% of HCCs occur in developing countries. Due to the advancement in human genomics from last two decades, researchers have discovered that cancer is caused by somatic aberrations in the host genome. This discovery has incited enthusiasm among cancer researchers. Many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease. Many cancer biology investigations are now using CRISPR as a standard approach. The CRISPR/Cas9 system has been shown to be effective in treating metastatic tumors, which is a big step toward discovering a cancer cure.
The Genome Editing Market is expected to grow from US$ 5.19 billion in 2021 to US$ 16.98 billion by 2028; it is estimated to grow at a CAGR of 18.4% during 2021–2028.
Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9 a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. For instance, in October 2020, the results of a petri dish study revealed that CRISPR/ Cas9 can potentially be used for altering a particular gene in nerve cells in the human brain, thereby slowing down the production of beta-amyloid protein, which is responsible for triggering the Alzheimer’s disease.
Recognizing the potential of genome editing techniques for studying and manipulating the genome, the Department of Biotechnology (DBT) has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development. This has helped in the identification of several novel regulators of cellular homeostasis, as well as multiple prospective therapeutic targets for lysosomal storage diseases. These factors for CRISPR system research are likely to favor the market's growth.
Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Horizon Discovery Group plc., Integrated DNA Technologies, GenScript, New England Biolabs, Eurofins Scientific, CRISPR Therapeutics, and Editas Medicine are among the leading companies operating in the genome editing market.
Based on technology, the genome editing market is segmented into CRISPR, TALEN, antisense, and other. The CRISPR segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. The market growth for this segment is attributed to incumbent usage of CRISPR, high volume consumption, and product innovation. CRISPR-Cas9 is faster, cheaper, and more accurate than the other technologies of DNA editing and is used for the wide applications. It is the simplest, most versatile, and precise method of genetic manipulation. Companies like Sangamo Therapeutics, Editas Medicine, Thermo Fisher Scientific, and Horizon Discovery Groups offer CRISPR.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Genomics Market will generate massive Revenue up to 2027
According to our latest study on “Genomics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technology, Product & Service, Application, End User, and Geography,” the market is expected to reach US$ 49,996.15 million by 2027 from US$ 19,084.74 million in 2019; it is expected to grow at a CAGR of 13.1% from 2020 to 2027. The market growth is attributed to the increasing prevalence of chronic diseases, declining cost of seq... moreGenomics Market will generate massive Revenue up to 2027
According to our latest study on “Genomics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technology, Product & Service, Application, End User, and Geography,” the market is expected to reach US$ 49,996.15 million by 2027 from US$ 19,084.74 million in 2019; it is expected to grow at a CAGR of 13.1% from 2020 to 2027. The market growth is attributed to the increasing prevalence of chronic diseases, declining cost of sequencing procedures, and growing funding for genomics. These drivers are expected to have significant short-, mid-, and long-term impacts on the market size. However, the dearth of skilled professionals is expected to hamper the growth of the market. The genomics market report also studies the ongoing opportunities and market trends that can have a significant impact on the growth of the market.
Genomics is defined as the study of a gene and its functioning. Genomics is used to examine the molecular mechanisms and the interaction of genetic and environmental factors in diseases. Genomics primarily encompasses four phenomena or disciplines—genomes, epistasis, heterosis, pleiotropy. The application of genomics is in various fields including medicine, biotechnology, anthropology, and other social sciences. The market scope provides detailed data and growth potential for the genomics market in diagnostics, drug discovery and development, precision/personalized medicine, agriculture & animal research, and others. The market report studies the lucrative areas in the market and aims to understand the ongoing genomics market trends and opportunities.
Genomics revolves around understanding genes and their functioning, interaction with other genetic and environmental factors which can then be used in diagnostics, drug discovery, and development, personalized medicine, agriculture & animal research, among others. The applications of genomics ranges from medicine to biotechnology to various social sciences. The market report aims to develop an understanding of the genomics market scope and trends expected to drive the market.
The genomics market is segmented based on technology, product & service, application, end user, and geography. The market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, market trends, technological advancements in the market, and market dynamics, along with the global analysis of the competitive landscape of the leading market players that are driving the market growth.
The primary technologies used in the genomics market are sequencing, microarray, PCR, nucleic acid extraction and purification, and others. The sequencing segment is expected to hold the major share of the genomics market size, which is expected to see robust growth during the forecast period. The growth of the segment is attributed to the increasing applications of sequencing to provide more precise treatment for ailments.
In the years ahead, the mHealth market will generate a massive amount of revenue
According to our latest study on "mHealth Market Forecast to 2028 – COVID-19 Impact and Analysis – by Service, Devices, and End User" the market is projected to reach US$ 410.39 billion by 2028 from US$ 70.83 billion in 2021; it is estimated to grow at a CAGR of 28.5% from 2021 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their game-changing str... moreIn the years ahead, the mHealth market will generate a massive amount of revenue
According to our latest study on "mHealth Market Forecast to 2028 – COVID-19 Impact and Analysis – by Service, Devices, and End User" the market is projected to reach US$ 410.39 billion by 2028 from US$ 70.83 billion in 2021; it is estimated to grow at a CAGR of 28.5% from 2021 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their game-changing strategies. The increasing adoption of smartphones and other mobile platforms, and rapid spread of COVID-19 are driving the mHealth market progress. However, security and privacy issues hinder the market growth.
Mobile health (mHealth) is a technique that includes the use of mobile commination devices, such as mobile phones, tablets, PDAs (personal digital assistants) and other wireless devices for distributing health services and information. mHealth unlocks the new opportunities for improving monitoring of chronic conditions and help with developing the prevention aspect of the healthcare system. mHealth enables to offer the services on consultation, care management, diagnosis, and self-management services by using information & communication technologies (ICT). It involves a wide variety of technologies and tactics to deliver virtual medical, health, and education services to the users. mHealth is a collection of means that is used to enhance care and education delivery. mHealth include instruments, apparatus, machines or software (including mobile applications) that are involved in the delivery of healthcare services.
Diabetes is a chronic, metabolic disorder that refers to the condition created by the body's inability to regulate glucose levels. The medical profession has postulated that patients could benefit from a system providing continuous glucose readings. The number of people with diabetes is increasing across the world, and ~90% of patients diagnosed with the condition have Type 2 diabetes mellitus; about one-fifth of people with Type 2 diabetes are on insulin treatment. The global burden of Type 2 diabetes has prompted efforts to develop mobile technologies for self-monitoring of blood glucose. More than 30 million Americans have some form of diabetes mellitus, which includes Type 1 diabetes, Type 2 diabetes, and gestational diabetes. Patients with diabetes have prolonged periods of high blood glucose, which results from insufficient levels of insulin or an inadequate cellular response to insulin. In the US, Type 2 (insulin-resistant) diabetes accounts for ~90–95% of all patients with diabetes, while Type 1 (insulin-insufficient) diabetes accounts for 5%. Management of diabetes varies depending on the type and severity. For Type 1 diabetes patients, insulin is a life-long treatment, with a wide spectrum of doses including multiple dose injections of insulin pumps (also known as continuous subcutaneous insulin infusion). A wide variety of home glucometers are available that are portable, inexpensive, reliable, and sensitive, and these machines use smaller volumes of blood than their conventional counterparts. Wearable insulin pumps and continuous glucose monitoring systems (CGMS) have given more freedom to many individuals with diabetes, along with providing scope for better treatments with real-time monitoring. Insulin deficiency can have serious side effects. By wearing CGMs and insulin pumps, patients are less likely to experience insulin deficiency. Moreover, when connected to a smartphone app, a CGMS or insulin pump gives continuous glucose updates. CGMS collect data so patients can identify trends and triggers.
It is predicted that the Passport Reader Market will generate massive revenues by 2027
According to the new research report titled “Passport Reader Market - Global Analysis and Forecast to 2027,” published by The Insight Partners, the market is expected to reach US$ 374.56 million by 2027, registering a CAGR of 7.7% during 2020–2027.
The rising adoption of technologically advanced border securing technologies by the Department of Homeland Security (DHS), including passport readers is boosting ... moreIt is predicted that the Passport Reader Market will generate massive revenues by 2027
According to the new research report titled “Passport Reader Market - Global Analysis and Forecast to 2027,” published by The Insight Partners, the market is expected to reach US$ 374.56 million by 2027, registering a CAGR of 7.7% during 2020–2027.
The rising adoption of technologically advanced border securing technologies by the Department of Homeland Security (DHS), including passport readers is boosting the market. The country consists of significantly higher number of airports which regularly cater to noteworthy number of international passengers (both arrival and departure). This factor has led the airport authorities and security authorities to implement and deploy advanced passport reading technologies in order to safeguard the country from illegal immigrants. Further, the rising deployment of passport readers among hotels, banks, and travel agencies is boosting the growth of passport reader market. Passport checks are an essential security measure for several businesses and institutions. In some instances, they are the most appropriate document to collect necessary customer information. Also, in some cases, they are mandatory by law, and the collected data must be shared with local authorities. As manual checking of passports is a tedious task in some businesses, they prefer using dedicated passport readers. In such cases, mobile passport scanning integrated with Mobile OCR is an ideal alternative.
The global passport reader market has been segmented into five major regions: North America, Europe, APAC, MEA, and SAM. North America holds the dominant share in the passport reader market, and APAC is expected to be the fastest-growing region in the global market. owing to significant illegal immigration between the US-Mexico Border, the government has taken stringent measures to eradicate illegal movements of people and cargo. There are 47 land ports of entry in the US-Mexico border, and all of them require primary inspection of passports against Homeland Security data. Further, in 2019, the CBP announced plans to accelerate the use of biometric technology to upgrade its systems as well as to deploy more self-service tools using mobile technology for verification purposes at all ports of entry by 2025. This would result in negatively impacting the market for passport readers in the country. North America is further anticipated to experience significant growth in its technology market in the coming years, and investors are presently capitalizing on these advancements to gain rewards in the future.
North America accounted for largest share in passport reader market in 2019
North America includes the US, Canada, and Mexico. To improve border security, the US Customs and Border Protection (CBP) requires international passenger information to be verified through the Advanced Passenger Information (API) system. The collected information of these international passengers is sent to the CBP for review before the flight arrival. Any violations in this process require returning at transfer points or destination by immigration authorities, which cost airlines a considerable amount of fines as well as associated costs. Thus, airlines are highly focused on proper passport and visa verification before the boarding of international passengers. In 2019, the US government announced its plans to deploy facial recognition technology across 20 key airports by 2021. This technology will be used on all the international as well as domestic passengers, which may impact the demand for passport readers across the country.
In February 2020, the US TSA deployed a new credential authentication technology (CTA) at Boston Logan International Airport. The technology enables verification of traveler ID and confirms their flight information in near-real-time manner, thus boosting security concerning the use of fake documents. A CAT scanner is capable of verifying ~2,500 different types of ID, including passports, as it is integrated with a passport reader. The TSA aims to install ~500 CAT units across 40 airports by the end of February 2020.
The Canadian government is also strengthening its border security measures owing to the rising number of immigrants in the country. The government aims to increase the country’s yearly immigration levels to 350,000 by 2021. Further, the new immigration level plan targets over 1 million immigrants from 2019–2021. In 2018, Billy Bishop Toronto City Airport implemented self-service kiosks to offer enhanced and hassle-free border clearance. The deployment of these kiosks initiated in March 2017, and the machines have already been deployed at key airports such as Ottawa, Vancouver, Edmonton, Montreal, Toronto (Terminal 3), Québec City, and Halifax.
There will be massive revenue generated by the Endodontic Reparative Cement market by 2027
According to a new market research study titled “Endodontic Reparative Cement Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product Type, Indication, and End User,” the global endodontic reparative cement market is expected to reach US$ 431.41 million in 2027 from US$ 310.87 million in 2019. The market is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights the t... moreThere will be massive revenue generated by the Endodontic Reparative Cement market by 2027
According to a new market research study titled “Endodontic Reparative Cement Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product Type, Indication, and End User,” the global endodontic reparative cement market is expected to reach US$ 431.41 million in 2027 from US$ 310.87 million in 2019. The market is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights the trends prevalent in the global endodontic reparative cement market and the factors driving the market along with those that act as deterrents to its growth. The market is driven by the growing number of endodontic procedures, and launch of advanced endodontic reparative cement varieties. However, lack of access to dental care and unavailability of insurance cover pose a challenge for the market players.
The high cost of root canal procedures and limited coverage for dental care act as challenges for endodontic procedures. However, the presence of alternative techniques such as vital pulp therapy (VPT) and basic root canal therapy (BRT) are expected to accelerate the use of endodontic reparative cement for sealing. The VPT has gained importance due to the long-term cumulative success rate, and it has shown effective results in children. It is indicated for the clinical diagnosis of reversible pulpitis. The VPT also includes procedures that involve indirect pulp capping, direct pulp capping, partial (superficial) pulpotomy, and complete (cervical) pulpotomy. These techniques utilize endodontic reparative cement, such as the MTA- and calcium hydroxide-based varieties, as cavity liner pulp capping agents. The cost-effectiveness of VPT, compared to root canal treatment, has gained much attention and is expected to fuel the demand for endodontic reparative cement in the coming years.
The developments in the endodontic reparative cement market have been characterized as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as launches, expansion, enhancement as well as relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnership, collaborations, alliance, and agreement & joint ventures. These activities have paved way for expansion of business and customer base of market players. The inorganic growth strategies undertaken by the companies operating in the global market of endodontic reparative cement include, merger & acquisition, collaboration, partnership, alliance, and agreement & joint venture.
During 2017 to 2020, companies such as, Coltene Group, and others have undertaken various inorganic strategies that have bought about remarkable developments in the endodontic reparative cement market. Inorganic growth strategies in the endodontic reparative cement market accounted for a share of around 50% among the growth strategies undertaken in the market. Similarly, during the year 2016 to 2020, various companies have made organic growth strategies in the endodontic reparative cement market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such are some of the companies that have been implementing various organic strategies that have helped the growth of the company and in turn have brought about various changes in the global endodontic reparative cement market.
Medical Imaging Market register to grow at a CAGR of 4.3% from 2021 to 2028
According to The Insight Partners’ research, the global Medical Imaging Market was valued at US$ 23,901.88 million in 2020 and is anticipated to be worth US$ 33,002.52 million by 2028, recording a stellar annual growth rate of 4.3% from 2021 to 2028. Introduction of technologically advanced systems and increasing demand for early diagnosis are the potential aspects assisting the market expansion.
Medical imaging is an ... moreMedical Imaging Market register to grow at a CAGR of 4.3% from 2021 to 2028
According to The Insight Partners’ research, the global Medical Imaging Market was valued at US$ 23,901.88 million in 2020 and is anticipated to be worth US$ 33,002.52 million by 2028, recording a stellar annual growth rate of 4.3% from 2021 to 2028. Introduction of technologically advanced systems and increasing demand for early diagnosis are the potential aspects assisting the market expansion.
Medical imaging is an integral part of clinical procedures. Radiologists use ultrasound, MRIs, and CT scans for proper diagnosis and treatment. Over the past few decades, the capabilities of medical imaging have increased radially. Besides, artificial intelligence (AI) has helped improve the critical aspects of healthcare industry, with medical imaging being a prime area of benefit. In February 2018, Aidoc, a deep learning startup, revealed world’s first comprehensive full-body technology that uses AI to analyze CT scans. In September 2018, Nvidia unveiled Nvidia Clara platform that integrates AI in future medical instruments.
Fatal disease such as cancer is now responsible for almost one in six deaths worldwide. Over 14 million people develop cancer every year, which is projected to exceed 21 million by 2030. In several cases, the disease is detected at a pretty advanced stage where it becomes gruesome for the doctors to treat any further. Research on early cancer diagnosis to commence the treatment quicker can help several countries to lower the death rate. New guidance from the WHO facilitates early diagnosis for patient survival. Around 75% of clinical decisions are subject to proper diagnostic tests. Initial diagnosis reduces the scale and cost of treatment and also lowers the possible pain and suffering. Medical imaging simplifies the diagnostic process and help determine the suitable treatment. These aforementioned parameters foster the global medical imaging market.
On the other hand, the declining reimbursements hinder the growth of global medical imaging market.
The Medical Robots Market is expected to generate massive revenues by 2028
According to The Insight Partners’ research, the global Medical Robots Market was valued at US$ 5,740.8 million in 2017 and is likely to hit US$ 28,776.5 million by 2025, expanding at 22.3% CAGR from 2017 to 2025. Increasing training programs for robotic surgeries, development of medical robots in Asia, and rising number of surgical procedures are the crucial factors credited for market expansion.
The use of robots is i... moreThe Medical Robots Market is expected to generate massive revenues by 2028
According to The Insight Partners’ research, the global Medical Robots Market was valued at US$ 5,740.8 million in 2017 and is likely to hit US$ 28,776.5 million by 2025, expanding at 22.3% CAGR from 2017 to 2025. Increasing training programs for robotic surgeries, development of medical robots in Asia, and rising number of surgical procedures are the crucial factors credited for market expansion.
The use of robots is increasing in all the medical disciplines, such as surgeries, therapies, rehabilitation, dispensing, and sanitation. Surgical robots are used to treat and repair damaged tissues and severe injuries, mostly in defense patient cases. In American Air Force, medical service provides training to the surgical teams to learn robotic treatments. The Society of European Robotic gynecological Surgeries (SERGS) has standardized treatments that use robot-assisted laparoscopic surgery. Thus, training medical personnel for robot-equipped practices is significantly surging.
The advent of medical robots has been increasing in Asia after being used in military and agriculture domains. Medical devices manufacturing companies in most of the developing Asian economies are investing to develop advanced medical robots for various purposes. The Tianjin University, based in China, developed a surgical robot, Micro Hand S, which went under clinical trials for human during 2014–2015. Also, the University of Hong Kong has been developing a robot exclusively for abdominal surgeries.
The statistics provided by Intuitive Surgical, Inc in 2017 stated that almost 877,000 surgical procedures were carried out by Da Vinci Surgical Systems, a medical robot application. According to the Agency for Healthcare Research and Quality (AHRQ) data, approximately 21.8 million invasive therapeutic surgeries were performed in the US in 2014. Owing to the advantages offered by medical robots in surgeries, various companies are availing the advanced robotic products to be used in the treatment and diagnosis of complex procedures. These factors altogether spurred the growth of global medical robots market.
On the contrary, the high cost of surgical procedures and installations hinders the growth of global medical robots market.
Trade Management Software Market register to grow at a CAGR of 10.9% from 2021 to 2028
According to The Insight Partners’ research, the global Trade Promotion Management Software Market was assessed at US$ 970.8 million in 2020 and is projected to be worth US$ 1,108.4 million by 2028, growing at 10.9% CAGR between 2021 and 2028. The rising expenditure on trade promotion management and increasing investments in trade promotion management strategies to boost sales are the crucial factors aiding m... moreTrade Management Software Market register to grow at a CAGR of 10.9% from 2021 to 2028
According to The Insight Partners’ research, the global Trade Promotion Management Software Market was assessed at US$ 970.8 million in 2020 and is projected to be worth US$ 1,108.4 million by 2028, growing at 10.9% CAGR between 2021 and 2028. The rising expenditure on trade promotion management and increasing investments in trade promotion management strategies to boost sales are the crucial factors aiding market proliferation.
Trade promotion acts as marketing tool and is a part of revenue management, which indicates marketing campaigns for retailers/wholesalers. These promotion strategies used by consumer goods’ companies potentially give much better results than earlier trade promotion methods. By using these strategies, both CPG manufacturers and retailers enhance ROI on their trade-promotion investments. Increase in the adoption of trade promotion management will eventually boost the demand for software to manage all functions effectively.
The trade promotion management software is a tool used by organizations to strategize, plan, execute, and manage operations related to trade promotion campaign. The trade process is subjected to be technology enabled in the coming years. Tools such as spreadsheet and excel are being used for budget preparation of all the related activities. To optimize promotion expenditure incurred by end-user companies, the need of a software is necessary.
Development of trade promotion strategy is the key to boost top-line revenue while maintaining customer loyalty in consumer goods, retail, or ecommerce companies. Presence of trade management software providers in the market, which helps targeted end users utilize trade promotion management software effectively, is driving the market growth.
On the other hand, the adoption of spreadsheet over software will likely hinder market augmentation over the forecast timeframe.
IVF Services Market leading with CAGR of 11.6% from 2020 to 2027
According to The Insight Partners' research, the global IVF services market was valued at US$ 13,496.29 million in 2019 and is projected to be worth US$ 31,613.7 million by 2027, growing at 11.6% CAGR during 2020–2027. Increasing incidence of infertility, rising number of fertility clinics and infertility services with government support, and growing number of product launches and developments are the key factors credited for mark... moreIVF Services Market leading with CAGR of 11.6% from 2020 to 2027
According to The Insight Partners' research, the global IVF services market was valued at US$ 13,496.29 million in 2019 and is projected to be worth US$ 31,613.7 million by 2027, growing at 11.6% CAGR during 2020–2027. Increasing incidence of infertility, rising number of fertility clinics and infertility services with government support, and growing number of product launches and developments are the key factors credited for market expansion.
The fertility rate is steadily declining globally owing to various factors, such as hormonal changes, age-related complications, and genetic defects. Moreover, chlamydia diseases cause about 4–5 million infections annually in the US. If left untreated, it can cause infertility in both sexes. Thus, the declining fertility rate leads to a significant increase in the demand for in vitro fertilization (IVF) services that help determine the fertility window in males and females.
Assisted reproductive technology (ART) now produces more than 50,000 babies per year in the US through 330,000 IVF procedures. Various government initiatives and changes in the legal system are driving the demand for assisted reproduction procedures in clinics, thus promoting the IVF services market.
However, the high procedural cost of reproductive techniques is hindering the market growth.
